XIAP discriminates between type I and type II FAS-induced apoptosis. - Wikidata - wikimedia - TriplyDB

XIAP discriminates between type I and type II FAS-induced apoptosis.

XIAP discriminates between type I and type II FAS-induced apoptosis.

http://www.wikidata.org/entity/Q34205704

about

Differential PKA activation and AKAP association determines cell fate in cancer cells Intestinal epithelial apoptosis initiates gut mucosal injury during extracorporeal membrane oxygenation in the newborn piglet Onto better TRAILs for cancer treatment Regulation of CD95/Fas signaling at the DISC Membrane trafficking of death receptors: implications on signalling Death receptor-ligand systems in cancer, cell death, and inflammation Getting TRAIL back on track for cancer therapy Cancer's Achilles' Heel: Apoptosis and Necroptosis to the Rescue Nitrosothiol signaling and protein nitrosation in cell death STL-based analysis of TRAIL-induced apoptosis challenges the notion of type I/type II cell line classification Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.The E. coli effector protein NleF is a caspase inhibitor.Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1 The role of apoptosis in megakaryocytes and platelets.Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways.Regulation of platelet lifespan by apoptosis.Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment Analysis of inhibitor of apoptosis protein family expression during mammary gland development.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cells Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation.SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cells.Hepatocyte death: a clear and present danger.IAP inhibitors enhance co-stimulation to promote tumor immunity.Inhibitor of Apoptosis (IAP) proteins as drug targets for the treatment of cancer BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis.Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease.The caspase-8 dimerization/dissociation balance is a highly potent regulator of caspase-8, -3, -6 signaling E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity Caspase functions in cell death and disease.The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis Caspase-8 binding to cardiolipin in giant unilamellar vesicles provides a functional docking platform for bid.Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella.Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells.Measuring and modeling apoptosis in single cells.Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo The essential role of evasion from cell death in cancer.

P2860

Q24337554-E88304DD-A146-48DB-AA52-A3A3B7422808 Q24597407-AEE24A92-DD2F-42DD-A70F-D7992067CC3A Q26768160-2A5FD91D-8885-4FC9-95D7-3E61B4143C4D Q26824629-CD62BFD3-BEF4-431D-8A0B-8C8FA31C10FE Q26852802-FFF302E8-5C60-4C80-BE6C-68E7926C7945 Q26865568-D7495A60-60DE-4E03-96A4-7FA095103C76 Q27027460-26131DE9-04B0-4AB4-B194-A6B8747C7294 Q28066868-274DED12-474D-4E8B-8C44-097C3FBCF800 Q28383796-80B7828D-14E7-45B2-9406-2E5C335F1BF7 Q28487858-0B3EA7C6-C8E1-476F-BB8B-A02551C3EA57 Q28548318-F88A3D49-438D-43A5-B819-EA4335A06198 Q30408769-B1EA543C-388B-4842-8664-2499F5E8C03B Q30456165-F36D93C9-53FF-422A-9F27-A04609530409 Q30503491-C8B0B7AD-E57A-4F23-86DA-1F27E8EE03A6 Q33412943-1CD020C4-F70B-46F4-8DEA-252A630837F1 Q33413970-5B8880BE-DC45-46D5-A186-4D2010AD8CFC Q33431667-1CFCE752-2619-4FE4-9522-A459EC9217C1 Q33589801-4C126724-A84F-4BA6-844B-42BFB4027B4C Q33618500-9EA617EE-FFB9-4D2D-9EAC-1FE3CBD7041E Q33841579-16072A3D-FD51-4241-92DC-5534261D49C2 Q33869744-3ECB22C9-327E-4049-98B5-030E171A8D47 Q33883310-584E900D-C353-4501-9F47-089430CE64E0 Q33955061-AF4D96E9-937B-4F01-B4AD-C47199558DBB Q34147508-D10967BA-0638-4C4F-8530-4C7CF87DF80F Q34161533-611FA90C-FAB8-47AA-B2E4-0710F709827F Q34167279-6A1C7E48-72C2-4085-BB8E-2D5C8AFBD078 Q34191999-30D95529-1AC2-4E17-AD4C-2606033AB874 Q34205236-BDFB13E7-5869-4054-B76A-A3A7D5C5CE4F Q34236748-43663452-E50F-4D22-8973-D0F70587770F Q34245177-29368EDF-730B-48F0-AF15-172602E31390 Q34336335-B6646358-C9AD-4808-85EB-D47351376B68 Q34428852-6DF318D1-FF62-49A8-8E6C-C839B7FA18D3 Q34435100-74CC2AD3-3457-421D-9281-07E34EBA85E9 Q34589533-8A794784-5D3C-4682-821A-26D62A89490D Q34736820-DD60F23A-5BEC-4164-B000-6321611C7398 Q34806506-FF5AD511-F8BA-415F-8F58-10B7778D7F4F Q34912378-0AEE60BA-3D77-42D6-8302-0F4AD66D65F1 Q34921455-5F32FBBB-BCA8-4BD0-9A55-1A9C4C3DCCDA Q35077031-152AC9F8-B1CA-43E8-AF2E-0E91C902E5FA Q35083049-539D7FE9-ACD0-4B0D-AB31-2DED75465DE1

P2860

XIAP discriminates between type I and type II FAS-induced apoptosis.

http://www.wikidata.org/entity/Q34205704

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

XIAP discriminates between type I and type II FAS-induced apoptosis.

@ast

XIAP discriminates between type I and type II FAS-induced apoptosis.

@en

XIAP discriminates between type I and type II FAS-induced apoptosis.

@nl

type

label

XIAP discriminates between type I and type II FAS-induced apoptosis.

@ast

XIAP discriminates between type I and type II FAS-induced apoptosis.

@en

XIAP discriminates between type I and type II FAS-induced apoptosis.

@nl

prefLabel

XIAP discriminates between type I and type II FAS-induced apoptosis.

@ast

XIAP discriminates between type I and type II FAS-induced apoptosis.

@en

XIAP discriminates between type I and type II FAS-induced apoptosis.

@nl

P1433

Q34205704-84023DD8-EC8B-41AA-B18B-23DEBECAE475

P1476

Q34205704-AAFADDB6-9A95-4655-88B1-0AD86FDA6C6F

P2093

Q34205704-1C8F49ED-758C-4DC1-B5BC-4CDB3C315EFD

Q34205704-5931213D-A395-45DF-A036-B2786FA92219

Q34205704-5D4E84D2-7ACC-424E-953F-A803240C26E1

Q34205704-6EF35652-6B8A-4A7C-B8B6-7C9F4DB1B17D

Q34205704-BD030A1B-2D5D-4520-AE0A-F40031F3A19F

Q34205704-E1C6ECC1-018C-4815-8F34-CC88010BE2A7

P2860

Q34205704-037BC084-93C9-40C5-8846-7F488816E6B7

Q34205704-0AC78816-F4F2-4174-B41C-5890DF3875C7

Q34205704-25C28CDF-003E-464B-A598-47A4390D36F7

Q34205704-27E504AE-FC30-453D-9BD5-A5719B1791EA

Q34205704-328B297D-DBD1-48B1-A5F3-83862329E56E

Q34205704-33F13C5A-9A8B-496C-BA01-832B09BFC6D1

Q34205704-356AAEB0-4CE2-4F71-BA8F-8785102D70F7

Q34205704-36144006-0EEA-4712-BE36-273AF6456BE9

Q34205704-45C21B2E-2C48-4119-8E45-02CCB98596E2

Q34205704-486BEA8D-312A-4E1C-BCBC-E60C8D41A083

P2888

Q34205704-CEC3111C-8D29-40CE-A176-5C70206DF2C0

P304

Q34205704-E38E2F55-CD7D-4659-926D-A272279283C1

P31

Q34205704-55F0C52F-5BFE-4B43-901F-D9950566FCB2

P356

Q34205704-FBBC6255-556A-47E0-A250-B965232AA0C1

P407

Q34205704-8EE72B66-93A1-4D13-929A-862E9CE68A54

P433

Q34205704-B951C26C-F37C-48A1-AFBF-3AED5838FF59

P478

Q34205704-D94DAED5-6D37-49DD-A375-AC5AA43F737E

P50

Q34205704-01554E97-F401-4D76-8102-BCE9E9A05870

Q34205704-1B1249D4-B345-4B1C-AB8B-1D8177436154

Q34205704-366C8ED8-2E15-4235-BD89-E6CB1B2AFB47

Q34205704-46128BFF-D10F-4008-A9CB-FE347A2DDAD4

Q34205704-7F780808-DA6D-40A3-A004-661DCD6FA751

Q34205704-FBD1F501-6F34-42CB-A798-3AFC918AF286

P577

Q34205704-FCB8315C-FE7F-4CAA-B576-8E6DD506310A

P5875

Q34205704-424C5609-BFD5-4FAB-813F-F18A55CE4F7C

P6179

Q34205704-FC750831-CC17-44CC-A602-A24D25E89EB2

P698

Q34205704-85D50588-334C-47F9-A7C8-002B156623CB

P932

Q34205704-5397B857-D879-4352-9019-5DABA1E094E2

P356

P1433

P1476

XIAP discriminates between type I and type II FAS-induced apoptosis.

@en

P2093

Christoph Borner

http://www.w3.org/2001/XMLSchema#string

David C S Huang

http://www.w3.org/2001/XMLSchema#string

Helen E Thomas

http://www.w3.org/2001/XMLSchema#string

Mark D McKenzie

http://www.w3.org/2001/XMLSchema#string

Philipp J Jost

http://www.w3.org/2001/XMLSchema#string

Stephanie Grabow

http://www.w3.org/2001/XMLSchema#string

P2860

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis

BID: a novel BH3 domain-only death agonist

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

CD95's deadly mission in the immune system

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis

P2888

P304

1035-1039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE08229

http://www.w3.org/2001/XMLSchema#string

P407

P433

7258

http://www.w3.org/2001/XMLSchema#string

P478

460

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Strasser

Philippe Bouillet

Thomas Kaufmann

P577

2009-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26689403

http://www.w3.org/2001/XMLSchema#string

P6179

1034993761

http://www.w3.org/2001/XMLSchema#string

P698

19626005

http://www.w3.org/2001/XMLSchema#string

P932

2956120

http://www.w3.org/2001/XMLSchema#string